Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anovulation × Letrozole × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Polycystic Ovary Syndrome 5 Advanced Breast Cancer 4 Recurrence 2 Ovarian Neoplasms 2 is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1 Uterine Cervical Neoplasms 1 Solid Tumor 1 Obesity 1 Neoplasm Metastasis 1 Infertility 1 Hypoxia 1 Hydatidiform Mole 1 HER2+ Breast Cancer 1 Gestational Trophoblastic Disease 1 Estrogen Receptor-positive Breast Cancer 1 Endometrioid Endometrial Cancer 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Diseases 1 Breast Cancer Organoids 1 Brain Neoplasms 1 Anovulation 1

Interventions

Metformin 2 Ultrasonography 1 Letrozole 1 Hematologic Tests 1 Clomiphene 1 Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551367 2015-09-16

LVCCFOROI

Ain Shams Maternity Hospital

Phase 2 Unknown

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡